• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical course of ovarian cancer patients under repeated stimulation of HAMA using MAb OC125 and B43.13.

作者信息

Baum R P, Noujaim A A, Nanci A, Moebus V, Hertel A, Niesen A, Donnerstag B, Sykes T, Boniface G, Hör G

机构信息

Department of Nuclear Medicine, University of Frankfurt, Germany.

出版信息

Hybridoma. 1993 Oct;12(5):583-9. doi: 10.1089/hyb.1993.12.583.

DOI:10.1089/hyb.1993.12.583
PMID:8300134
Abstract
摘要

相似文献

1
Clinical course of ovarian cancer patients under repeated stimulation of HAMA using MAb OC125 and B43.13.使用单克隆抗体OC125和B43.13反复刺激HAMA的卵巢癌患者的临床病程。
Hybridoma. 1993 Oct;12(5):583-9. doi: 10.1089/hyb.1993.12.583.
2
Influence of human anti-murine antibodies on in vitro assays in ovarian cancer patients.人抗鼠抗体对卵巢癌患者体外检测的影响。
Hybridoma. 1993 Oct;12(5):571-6. doi: 10.1089/hyb.1993.12.571.
3
Are human anti-idiotypic anti-OC125 antibodies formed after immunization with the anti-CA125 antibody B43.13?用抗CA125抗体B43.13免疫后是否会形成人抗独特型抗OC125抗体？
Hybridoma. 1997 Feb;16(1):59-63. doi: 10.1089/hyb.1997.16.59.
4
Idiotypic cascades after MAb OC125 application.
Hybridoma. 1993 Oct;12(5):577-82. doi: 10.1089/hyb.1993.12.577.
5
False changes in CA 125 levels in ovarian cancer patients after infusion of OC125 fragments for diagnostic and therapeutic purpose.为诊断和治疗目的输注OC125片段后，卵巢癌患者CA 125水平出现假性变化。
Arch Gynecol Obstet. 1994;255(1):9-18. doi: 10.1007/BF02390669.
6
Anti-murine antibody response to mouse monoclonal antibodies in cancer patients.癌症患者对小鼠单克隆抗体的抗小鼠抗体反应。
Jpn J Cancer Res. 1997 Sep;88(9):895-9. doi: 10.1111/j.1349-7006.1997.tb00466.x.
7
Influence of MAb (F(Ab)2 OC 125 on the survival rate of ovarian carcinoma patients.单克隆抗体（F(Ab)2 OC 125）对卵巢癌患者生存率的影响。
Hybridoma. 1993 Oct;12(5):567-70. doi: 10.1089/hyb.1993.12.567.
8
Level of anti-mouse-antibody response induced by bi-specific monoclonal antibody OC/TR in ovarian-carcinoma patients is associated with longer survival.双特异性单克隆抗体OC/TR在卵巢癌患者中诱导产生的抗小鼠抗体反应水平与更长的生存期相关。
Int J Cancer. 1999 Feb 19;84(1):62-8. doi: 10.1002/(sici)1097-0215(19990219)84:1<62::aid-ijc12>3.0.co;2-t.
9
Antiidiotype induction therapy: evidence for the induction of immune response through the idiotype network in patients with ovarian cancer after administration of anti-CA125 murine monoclonal antibody B43.13.抗独特型诱导疗法：在给予抗CA125鼠单克隆抗体B43.13后，卵巢癌患者通过独特型网络诱导免疫反应的证据。
Hybridoma. 1995 Apr;14(2):199-203. doi: 10.1089/hyb.1995.14.199.
10
Anti-idiotypic monoclonal antibodies against anti-ovarian carcinoma monoclonal antibody COC166-9. Generation and application.
Chin Med J (Engl). 1994 Feb;107(2):99-103.

引用本文的文献

1
Mucin-Targeted Antibodies for Ovarian Cancer.用于卵巢癌的黏蛋白靶向抗体
Semin Nucl Med. 2025 Jul 3. doi: 10.1053/j.semnuclmed.2025.06.007.
2
Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma.先前存在针对 hu14.18K322A mAb Fc 区域的治疗性抗体与复发性神经母细胞瘤患者的结局相关。
J Immunother Cancer. 2020 Mar;8(1). doi: 10.1136/jitc-2020-000590.
3
Immuno-PET of epithelial ovarian cancer: harnessing the potential of CA125 for non-invasive imaging.
免疫 PET 检测上皮性卵巢癌：利用 CA125 进行非侵入性成像。
EJNMMI Res. 2014 Dec;4(1):60. doi: 10.1186/s13550-014-0060-4. Epub 2014 Nov 12.
4
Immunological response induced by abagovomab as a maintenance therapy in patients with epithelial ovarian cancer: relationship with survival-a substudy of the MIMOSA trial.阿巴戈伏单抗作为上皮性卵巢癌患者维持治疗所诱导的免疫反应：与生存的关系——MIMOSA试验的一项子研究
Cancer Immunol Immunother. 2014 Oct;63(10):1037-45. doi: 10.1007/s00262-014-1569-0. Epub 2014 Jun 21.
5
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.MUC16（CA125）：癌症治疗的肿瘤生物标志物，一项正在进行的工作。
Mol Cancer. 2014 May 29;13:129. doi: 10.1186/1476-4598-13-129.
6
Monoclonal antibodies in gynecological cancer: a critical point of view.妇科癌症中的单克隆抗体：批判性观点
Clin Dev Immunol. 2011;2011:890758. doi: 10.1155/2011/890758. Epub 2011 Dec 26.
7
Abagovomab: an anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer.Abagovomab：一种针对卵巢癌的抗独特型 CA-125 靶向免疫治疗剂。
Immunotherapy. 2011 Feb;3(2):153-62. doi: 10.2217/imt.10.100.
8
CA125 in ovarian cancer.卵巢癌中的CA125
Biomark Med. 2007 Dec;1(4):513-23. doi: 10.2217/17520363.1.4.513.
9
The detection, treatment, and biology of epithelial ovarian cancer.上皮性卵巢癌的检测、治疗和生物学特性。
J Ovarian Res. 2010 Mar 29;3:8. doi: 10.1186/1757-2215-3-8.